FDA’s Opioid Labeling Initiative Is Smoke and Mirrors

(MedPage Today) — The FDA recently announced new requirements for opioid medications to be labeled to emphasize “the safety risks of long-term use.” The labeling updates are based on two required postmarketing observational studies on all new…